OptimizeRx Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2009
Net Income	-17.57	-11.44	0.38	-2.21	-3.14	Upgrade
Depreciation & Amortization	2.4	2.02	1.97	2.08	1.28	Upgrade
Share-Based Compensation	13.72	15.75	5.49	3.17	2.26	Upgrade
Other Operating Activities	-5.79	4.32	-7.11	-9.35	-2.06	Upgrade
Operating Cash Flow	-7.24	10.65	0.73	-6.31	-1.66	Upgrade
Operating Cash Flow Growth	-	1367.43%	-	-	-	Upgrade
Capital Expenditures	-0.86	-0.24	-0.46	-0.11	-0.09	Upgrade
Acquisitions	-80.41	-2	0	0	-8.99	Upgrade
Change in Investments	55.93	-55.93	0	0	0	Upgrade
Other Investing Activities	-	-	-0.02	-0.01	-1.5	Upgrade
Investing Cash Flow	-25.34	-58.18	-0.49	-0.12	-10.58	Upgrade
Share Issuance / Repurchase	-7.8	-18.95	75.54	2.49	22.18	Upgrade
Debt Issued / Paid	36.02	0	0	0	0	Upgrade
Other Financing Activities	-	-	-1.61	-4.39	-	Upgrade
Financing Cash Flow	28.22	-18.95	73.92	-1.9	22.18	Upgrade
Net Cash Flow	-4.36	-66.47	74.16	-8.34	9.94	Upgrade
Free Cash Flow	-8.1	10.41	0.26	-6.42	-1.75	Upgrade
Free Cash Flow Growth	-	3879.92%	-	-	-	Upgrade
Free Cash Flow Margin	-11.33%	16.67%	0.43%	-14.83%	-7.11%	Upgrade
Free Cash Flow Per Share	-0.47	0.58	0.01	-0.43	-0.13	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).